search
Back to results

Aerobic Exercise as add-on Treatment for Inpatients With Depression

Primary Purpose

Depression

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Aerobic exercise
Placebo control
Sponsored by
University Hospital, Basel, Switzerland
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Depression

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Inpatient treatment on the Depression ward
  • International Classification of Diseases (ICD)-10: F32, F33 or F31
  • HDRS-17>16 Points
  • written informed consent

Exclusion Criteria:

  • Any physical condition that prohibits endurance exercise
  • 3 or more cardiovascular risk factors (hypertonia, family history, smoking, hypertriglyceridemia, diabetes)
  • pathological ECG
  • BMI > 35 kg/m2
  • Pregnancy
  • acute suicidal Ideation
  • comorbid substance dependence (except nicotine)
  • Major comorbid psychiatric disorder
  • regular high intensity exercise prior to treatment

Sites / Locations

  • Psychiatric University Hospital
  • Psychiatric Services Solothurn

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Exercise (IG)

Control (CG)

Arm Description

Aerobic exercise three times per week on indoor bicycles at 60 to 75% of maximal heartrate aiming at a weekly total of 17.5kcal/kg bodyweight for 6 consecutive weeks. The exercise will take place under supervision. At the end of every week physical fitness is evaluated by the queens step test.No other activities with moderate or high intensity are allowed throughout the intervention time.

Basic stretching and mobilisation program 3 times per week each for approx. 40 minutes, also under supervision for 6 consecutive weeks. At the end of every week physical fitness is evaluated by the queens step test.At the end of every week physical fitness is evaluated by the queens step test.No other activities with moderate or high intensity are allowed throughout the intervention time.

Outcomes

Primary Outcome Measures

Depressive Symptoms self rated
Change in Score of Hamilton Depression Rating Scale (HDRS-17) from baseline until 6 months follow-up
Depressive Symptoms physician rated
Change in Score of Beck Depression Inventory (BDI) from baseline until 6 months follow-up

Secondary Outcome Measures

Cortisol awakening response (CAR)
Change of Salivary cortisol increase (Area under the curve, measured at awakening, +10, +20 and +30 minutes) from baseline until 6 months follow-up
Brain derived neurotrophic factor (Serum-BDNF)
Change of Serum-BDNF
Sleep (Subjective sleep Quality)
Change of Score of Pittsburgh sleep quality index (PSQI) from baseline until follow-up
Sleep (Polysomnography)
Change in sleep stages between baseline and follow-up
Cognition
Change in performance in Executive functions (alertness, working memory, flexibility, go/nogo, divided attention) measured by "Testbatterie zur Aufmerksamkeitsprüfung" (TAP)
Social stress - cortisol
Change of Salivary cortisol-course (Area under the curve) during Trier Social Stress Test (TSST)
Social stress - heartrate
Change of heartrate-course during Trier Social Stress Test (TSST)
Psychological symptoms
Change of scores in Symptom Checklist (SCL-90R) from baseline until follow-up
Mental Toughness
Change in score in Mental Toughness Questionnaire (MTQ18)from baseline until follow-up
Physical activity
Change of weekly physical activity as self reported by the International Physical Activity Questionnaire - Short Version (IPAQ-short)
Sleep related personality traits
Change in Focussing and Rumination subscores of the "Fragebogen zur Erfassung von Persönlichkeitsmerkmalen Schlafgestörter" (FEPS II)
Body Mass Index (BMI)
Change(BMI)
Resting Heartrate (HR)
Change of HR
Blood Pressure (BP)
Change of BP
TNF-Alpha (additional value assessed/Amendment 1)
Change of TNF-alpha

Full Information

First Posted
January 26, 2016
Last Updated
April 10, 2017
Sponsor
University Hospital, Basel, Switzerland
Collaborators
Psychiatric Hospital of the University of Basel, University of Basel, Solothurner Spitäler AG
search

1. Study Identification

Unique Protocol Identification Number
NCT02679053
Brief Title
Aerobic Exercise as add-on Treatment for Inpatients With Depression
Official Title
Aerobic Exercise as add-on Treatment for Inpatients With Depression: Effects and Biomarkers
Study Type
Interventional

2. Study Status

Record Verification Date
April 2017
Overall Recruitment Status
Completed
Study Start Date
October 2013 (undefined)
Primary Completion Date
February 2016 (Actual)
Study Completion Date
March 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Basel, Switzerland
Collaborators
Psychiatric Hospital of the University of Basel, University of Basel, Solothurner Spitäler AG

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of the study is to evaluate the effect of 6 weeks of aerobic endurance exercise as adon treatment for moderately to severely depressed inpatients. Endpoints are symptom severity, psychological variables, cognitive symptoms, sleep, hypothalamic-pituitary-adrenal axis (HPA-axis), Brain-derived neurotrophic factor (BDNF) and heartrate variability (HRV). Amendment 1 (Nov. 2016): additional evaluation of TNF-alpha at baseline, +2 weeks and post (+6weeks) in already existing blood samples.
Detailed Description
Patients are randomly assigned to the intervention group (IG) or control group (CG). The IG will train three times per week on indoor bicycles at 60 to 75% of maximal heartrate aiming at a weekly total of 17.5kcal/kg bodyweight for 6 consecutive weeks. The exercise will take place under supervision. CG will absolve a basic stretching and mobilisation program 3 times per week, also under supervision for 6 consecutive weeks. At the end of every week physical fitness is evaluated by the queens step test. No other activities with moderate or high intensity are allowed throughout the intervention time. All patients will participate in the multimodal treatment program of the depression ward, which includes pharmacotherapy, psychotherapy and specialized therapies such as art therapy and ergotherapy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
49 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Exercise (IG)
Arm Type
Experimental
Arm Description
Aerobic exercise three times per week on indoor bicycles at 60 to 75% of maximal heartrate aiming at a weekly total of 17.5kcal/kg bodyweight for 6 consecutive weeks. The exercise will take place under supervision. At the end of every week physical fitness is evaluated by the queens step test.No other activities with moderate or high intensity are allowed throughout the intervention time.
Arm Title
Control (CG)
Arm Type
Placebo Comparator
Arm Description
Basic stretching and mobilisation program 3 times per week each for approx. 40 minutes, also under supervision for 6 consecutive weeks. At the end of every week physical fitness is evaluated by the queens step test.At the end of every week physical fitness is evaluated by the queens step test.No other activities with moderate or high intensity are allowed throughout the intervention time.
Intervention Type
Behavioral
Intervention Name(s)
Aerobic exercise
Intervention Type
Behavioral
Intervention Name(s)
Placebo control
Primary Outcome Measure Information:
Title
Depressive Symptoms self rated
Description
Change in Score of Hamilton Depression Rating Scale (HDRS-17) from baseline until 6 months follow-up
Time Frame
Baseline (pre), 1 week, 2 weeks, 6 weeks (post), 6 months (followup)
Title
Depressive Symptoms physician rated
Description
Change in Score of Beck Depression Inventory (BDI) from baseline until 6 months follow-up
Time Frame
Baseline (pre), 1 week, 2 weeks, 6 weeks (post), 6 months (follow-up)
Secondary Outcome Measure Information:
Title
Cortisol awakening response (CAR)
Description
Change of Salivary cortisol increase (Area under the curve, measured at awakening, +10, +20 and +30 minutes) from baseline until 6 months follow-up
Time Frame
Baseline (pre), 2 weeks, 6 weeks (post), 6 months (follow-up)
Title
Brain derived neurotrophic factor (Serum-BDNF)
Description
Change of Serum-BDNF
Time Frame
Baseline (pre), 2 weeks, 6 weeks (post), 6 months (followup)
Title
Sleep (Subjective sleep Quality)
Description
Change of Score of Pittsburgh sleep quality index (PSQI) from baseline until follow-up
Time Frame
Baseline (pre), 6 weeks (post), 6 months (followup)
Title
Sleep (Polysomnography)
Description
Change in sleep stages between baseline and follow-up
Time Frame
Baseline (pre), 6 weeks (post)
Title
Cognition
Description
Change in performance in Executive functions (alertness, working memory, flexibility, go/nogo, divided attention) measured by "Testbatterie zur Aufmerksamkeitsprüfung" (TAP)
Time Frame
Baseline (pre), 6 weeks (post), 6 months (followup)
Title
Social stress - cortisol
Description
Change of Salivary cortisol-course (Area under the curve) during Trier Social Stress Test (TSST)
Time Frame
Baseline (pre), 6 weeks (post)
Title
Social stress - heartrate
Description
Change of heartrate-course during Trier Social Stress Test (TSST)
Time Frame
Baseline (pre), 6 weeks (post)
Title
Psychological symptoms
Description
Change of scores in Symptom Checklist (SCL-90R) from baseline until follow-up
Time Frame
Baseline (pre), 6 weeks (post), 6 months (follow-up)
Title
Mental Toughness
Description
Change in score in Mental Toughness Questionnaire (MTQ18)from baseline until follow-up
Time Frame
Baseline (pre), 6 weeks (post), 6 months (followup)
Title
Physical activity
Description
Change of weekly physical activity as self reported by the International Physical Activity Questionnaire - Short Version (IPAQ-short)
Time Frame
Baseline (pre), 6 months (follow-up)
Title
Sleep related personality traits
Description
Change in Focussing and Rumination subscores of the "Fragebogen zur Erfassung von Persönlichkeitsmerkmalen Schlafgestörter" (FEPS II)
Time Frame
Baseline (pre), 6 weeks (post), 6 months (followup)
Title
Body Mass Index (BMI)
Description
Change(BMI)
Time Frame
Baseline (pre), 6 weeks (post), 6 months (followup)
Title
Resting Heartrate (HR)
Description
Change of HR
Time Frame
Baseline (pre), 6 weeks (post), 6 months (followup)
Title
Blood Pressure (BP)
Description
Change of BP
Time Frame
Baseline (pre), 6 weeks (post), 6 months (followup)
Title
TNF-Alpha (additional value assessed/Amendment 1)
Description
Change of TNF-alpha
Time Frame
Baseline (pre), 2 weeks (post), 6 weeks (post)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Inpatient treatment on the Depression ward International Classification of Diseases (ICD)-10: F32, F33 or F31 HDRS-17>16 Points written informed consent Exclusion Criteria: Any physical condition that prohibits endurance exercise 3 or more cardiovascular risk factors (hypertonia, family history, smoking, hypertriglyceridemia, diabetes) pathological ECG BMI > 35 kg/m2 Pregnancy acute suicidal Ideation comorbid substance dependence (except nicotine) Major comorbid psychiatric disorder regular high intensity exercise prior to treatment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christian Imboden, MD, Dr.
Organizational Affiliation
Solothurner Spitäler AG
Official's Role
Principal Investigator
Facility Information:
Facility Name
Psychiatric University Hospital
City
Basel
ZIP/Postal Code
4012
Country
Switzerland
Facility Name
Psychiatric Services Solothurn
City
Solothurn
ZIP/Postal Code
4503
Country
Switzerland

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
31073292
Citation
Imboden C, Gerber M, Beck J, Eckert A, Puhse U, Holsboer-Trachsler E, Hatzinger M. Effects of Aerobic Exercise as Add-On Treatment for Inpatients With Moderate to Severe Depression on Depression Severity, Sleep, Cognition, Psychological Well-Being, and Biomarkers: Study Protocol, Description of Study Population, and Manipulation Check. Front Psychiatry. 2019 Apr 25;10:262. doi: 10.3389/fpsyt.2019.00262. eCollection 2019.
Results Reference
derived

Learn more about this trial

Aerobic Exercise as add-on Treatment for Inpatients With Depression

We'll reach out to this number within 24 hrs